nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—CYP2C9—Anastrozole—breast cancer	0.129	0.332	CbGbCtD
Glimepiride—CYP2C9—Idarubicin—breast cancer	0.0981	0.251	CbGbCtD
Glimepiride—CYP2C9—Capecitabine—breast cancer	0.0538	0.138	CbGbCtD
Glimepiride—CYP2C9—Tamoxifen—breast cancer	0.0433	0.111	CbGbCtD
Glimepiride—CYP2C9—Paclitaxel—breast cancer	0.0337	0.0863	CbGbCtD
Glimepiride—CYP2C9—Fluorouracil—breast cancer	0.0319	0.0817	CbGbCtD
Glimepiride—Glyburide—CPT1A—breast cancer	0.0025	0.279	CrCbGaD
Glimepiride—KCNJ11—mammary gland—breast cancer	0.00221	0.167	CbGeAlD
Glimepiride—ABCC8—mammary gland—breast cancer	0.00204	0.153	CbGeAlD
Glimepiride—Gliclazide—VEGFA—breast cancer	0.0018	0.201	CrCbGaD
Glimepiride—Glyburide—ABCC1—breast cancer	0.00111	0.124	CrCbGaD
Glimepiride—ABCC8—endometrium—breast cancer	0.00102	0.0766	CbGeAlD
Glimepiride—ABCC8—pituitary gland—breast cancer	0.000922	0.0693	CbGeAlD
Glimepiride—KCNJ11—female reproductive system—breast cancer	0.000916	0.0689	CbGeAlD
Glimepiride—CYP2C9—mammary gland—breast cancer	0.000912	0.0686	CbGeAlD
Glimepiride—KCNJ11—adrenal gland—breast cancer	0.000894	0.0673	CbGeAlD
Glimepiride—KCNJ11—female gonad—breast cancer	0.000834	0.0627	CbGeAlD
Glimepiride—ABCC8—adrenal gland—breast cancer	0.000823	0.0619	CbGeAlD
Glimepiride—KCNJ11—endocrine gland—breast cancer	0.000775	0.0583	CbGeAlD
Glimepiride—Chlorpropamide—PTGS1—breast cancer	0.000739	0.0825	CrCbGaD
Glimepiride—ABCC8—endocrine gland—breast cancer	0.000714	0.0537	CbGeAlD
Glimepiride—Glipizide—CYP3A4—breast cancer	0.000597	0.0667	CrCbGaD
Glimepiride—Glyburide—ABCG2—breast cancer	0.000583	0.0651	CrCbGaD
Glimepiride—KCNJ11—lymph node—breast cancer	0.000536	0.0403	CbGeAlD
Glimepiride—Gliclazide—ALB—breast cancer	0.000484	0.0541	CrCbGaD
Glimepiride—CYP2C9—female reproductive system—breast cancer	0.000377	0.0284	CbGeAlD
Glimepiride—Chlorpropamide—ABCB1—breast cancer	0.000359	0.0401	CrCbGaD
Glimepiride—CYP2C9—endocrine gland—breast cancer	0.000319	0.024	CbGeAlD
Glimepiride—Glyburide—CYP3A4—breast cancer	0.000291	0.0325	CrCbGaD
Glimepiride—Glyburide—ALB—breast cancer	0.000254	0.0284	CrCbGaD
Glimepiride—Glyburide—ABCB1—breast cancer	0.000243	0.0271	CrCbGaD
Glimepiride—Dry mouth—Docetaxel—breast cancer	0.000163	0.000338	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000163	0.000338	CcSEcCtD
Glimepiride—Fatigue—Paclitaxel—breast cancer	0.000163	0.000337	CcSEcCtD
Glimepiride—Hepatitis—Methotrexate—breast cancer	0.000162	0.000336	CcSEcCtD
Glimepiride—Sweating—Epirubicin—breast cancer	0.000162	0.000336	CcSEcCtD
Glimepiride—Pollakiuria—Doxorubicin—breast cancer	0.000162	0.000336	CcSEcCtD
Glimepiride—Asthenia—Gemcitabine—breast cancer	0.000162	0.000335	CcSEcCtD
Glimepiride—Confusional state—Docetaxel—breast cancer	0.000161	0.000334	CcSEcCtD
Glimepiride—Anxiety—Capecitabine—breast cancer	0.000161	0.000334	CcSEcCtD
Glimepiride—Photosensitivity reaction—Doxorubicin—breast cancer	0.00016	0.000332	CcSEcCtD
Glimepiride—Anaphylactic shock—Docetaxel—breast cancer	0.00016	0.000332	CcSEcCtD
Glimepiride—Weight increased—Doxorubicin—breast cancer	0.00016	0.000331	CcSEcCtD
Glimepiride—Pruritus—Gemcitabine—breast cancer	0.000159	0.000331	CcSEcCtD
Glimepiride—Nausea—Thiotepa—breast cancer	0.000159	0.00033	CcSEcCtD
Glimepiride—Diarrhoea—Irinotecan—breast cancer	0.000158	0.000328	CcSEcCtD
Glimepiride—Diarrhoea—Mitoxantrone—breast cancer	0.000158	0.000328	CcSEcCtD
Glimepiride—Dry mouth—Capecitabine—breast cancer	0.000158	0.000327	CcSEcCtD
Glimepiride—Agranulocytosis—Epirubicin—breast cancer	0.000158	0.000327	CcSEcCtD
Glimepiride—Shock—Docetaxel—breast cancer	0.000157	0.000326	CcSEcCtD
Glimepiride—Pruritus—Fluorouracil—breast cancer	0.000157	0.000325	CcSEcCtD
Glimepiride—Thrombocytopenia—Docetaxel—breast cancer	0.000157	0.000325	CcSEcCtD
Glimepiride—Drowsiness—Doxorubicin—breast cancer	0.000156	0.000324	CcSEcCtD
Glimepiride—Visual impairment—Methotrexate—breast cancer	0.000156	0.000324	CcSEcCtD
Glimepiride—Confusional state—Capecitabine—breast cancer	0.000156	0.000324	CcSEcCtD
Glimepiride—Tachycardia—Docetaxel—breast cancer	0.000156	0.000324	CcSEcCtD
Glimepiride—Feeling abnormal—Paclitaxel—breast cancer	0.000155	0.000322	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000155	0.000322	CcSEcCtD
Glimepiride—Bradycardia—Epirubicin—breast cancer	0.000155	0.00032	CcSEcCtD
Glimepiride—Gastrointestinal pain—Paclitaxel—breast cancer	0.000154	0.00032	CcSEcCtD
Glimepiride—Diarrhoea—Gemcitabine—breast cancer	0.000154	0.00032	CcSEcCtD
Glimepiride—Erythema multiforme—Methotrexate—breast cancer	0.000153	0.000318	CcSEcCtD
Glimepiride—Dizziness—Irinotecan—breast cancer	0.000153	0.000317	CcSEcCtD
Glimepiride—Jaundice—Doxorubicin—breast cancer	0.000153	0.000316	CcSEcCtD
Glimepiride—Anorexia—Docetaxel—breast cancer	0.000152	0.000316	CcSEcCtD
Glimepiride—Shock—Capecitabine—breast cancer	0.000152	0.000316	CcSEcCtD
Glimepiride—Hepatitis—Epirubicin—breast cancer	0.000152	0.000315	CcSEcCtD
Glimepiride—Diarrhoea—Fluorouracil—breast cancer	0.000152	0.000314	CcSEcCtD
Glimepiride—Thrombocytopenia—Capecitabine—breast cancer	0.000152	0.000314	CcSEcCtD
Glimepiride—Tachycardia—Capecitabine—breast cancer	0.000151	0.000313	CcSEcCtD
Glimepiride—Sweating—Doxorubicin—breast cancer	0.00015	0.000311	CcSEcCtD
Glimepiride—Urticaria—Paclitaxel—breast cancer	0.00015	0.000311	CcSEcCtD
Glimepiride—Hyperhidrosis—Capecitabine—breast cancer	0.00015	0.00031	CcSEcCtD
Glimepiride—Hypotension—Docetaxel—breast cancer	0.000149	0.00031	CcSEcCtD
Glimepiride—Abdominal pain—Paclitaxel—breast cancer	0.000149	0.000309	CcSEcCtD
Glimepiride—Anorexia—Capecitabine—breast cancer	0.000148	0.000306	CcSEcCtD
Glimepiride—Vomiting—Mitoxantrone—breast cancer	0.000147	0.000305	CcSEcCtD
Glimepiride—Vomiting—Irinotecan—breast cancer	0.000147	0.000305	CcSEcCtD
Glimepiride—Dizziness—Fluorouracil—breast cancer	0.000147	0.000304	CcSEcCtD
Glimepiride—Visual impairment—Epirubicin—breast cancer	0.000146	0.000303	CcSEcCtD
Glimepiride—Agranulocytosis—Doxorubicin—breast cancer	0.000146	0.000303	CcSEcCtD
Glimepiride—Rash—Mitoxantrone—breast cancer	0.000146	0.000302	CcSEcCtD
Glimepiride—Rash—Irinotecan—breast cancer	0.000146	0.000302	CcSEcCtD
Glimepiride—Dermatitis—Mitoxantrone—breast cancer	0.000146	0.000302	CcSEcCtD
Glimepiride—Dermatitis—Irinotecan—breast cancer	0.000146	0.000302	CcSEcCtD
Glimepiride—Headache—Irinotecan—breast cancer	0.000145	0.0003	CcSEcCtD
Glimepiride—Headache—Mitoxantrone—breast cancer	0.000145	0.0003	CcSEcCtD
Glimepiride—Hypotension—Capecitabine—breast cancer	0.000145	0.0003	CcSEcCtD
Glimepiride—Insomnia—Docetaxel—breast cancer	0.000145	0.0003	CcSEcCtD
Glimepiride—Paraesthesia—Docetaxel—breast cancer	0.000144	0.000298	CcSEcCtD
Glimepiride—Erythema multiforme—Epirubicin—breast cancer	0.000144	0.000298	CcSEcCtD
Glimepiride—Vomiting—Gemcitabine—breast cancer	0.000143	0.000297	CcSEcCtD
Glimepiride—Bradycardia—Doxorubicin—breast cancer	0.000143	0.000296	CcSEcCtD
Glimepiride—Dyspnoea—Docetaxel—breast cancer	0.000143	0.000296	CcSEcCtD
Glimepiride—Somnolence—Docetaxel—breast cancer	0.000142	0.000295	CcSEcCtD
Glimepiride—Rash—Gemcitabine—breast cancer	0.000142	0.000295	CcSEcCtD
Glimepiride—Dermatitis—Gemcitabine—breast cancer	0.000142	0.000294	CcSEcCtD
Glimepiride—Erythema—Methotrexate—breast cancer	0.000141	0.000293	CcSEcCtD
Glimepiride—Malnutrition—Methotrexate—breast cancer	0.000141	0.000293	CcSEcCtD
Glimepiride—Headache—Gemcitabine—breast cancer	0.000141	0.000293	CcSEcCtD
Glimepiride—Vomiting—Fluorouracil—breast cancer	0.000141	0.000292	CcSEcCtD
Glimepiride—Dyspepsia—Docetaxel—breast cancer	0.000141	0.000292	CcSEcCtD
Glimepiride—Hepatitis—Doxorubicin—breast cancer	0.00014	0.000291	CcSEcCtD
Glimepiride—Insomnia—Capecitabine—breast cancer	0.00014	0.00029	CcSEcCtD
Glimepiride—Rash—Fluorouracil—breast cancer	0.00014	0.00029	CcSEcCtD
Glimepiride—Dermatitis—Fluorouracil—breast cancer	0.00014	0.000289	CcSEcCtD
Glimepiride—Paraesthesia—Capecitabine—breast cancer	0.000139	0.000288	CcSEcCtD
Glimepiride—Decreased appetite—Docetaxel—breast cancer	0.000139	0.000288	CcSEcCtD
Glimepiride—Hypersensitivity—Paclitaxel—breast cancer	0.000139	0.000288	CcSEcCtD
Glimepiride—Headache—Fluorouracil—breast cancer	0.000139	0.000288	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Docetaxel—breast cancer	0.000138	0.000286	CcSEcCtD
Glimepiride—Dyspnoea—Capecitabine—breast cancer	0.000138	0.000286	CcSEcCtD
Glimepiride—Fatigue—Docetaxel—breast cancer	0.000138	0.000286	CcSEcCtD
Glimepiride—Nausea—Irinotecan—breast cancer	0.000137	0.000285	CcSEcCtD
Glimepiride—Nausea—Mitoxantrone—breast cancer	0.000137	0.000285	CcSEcCtD
Glimepiride—Dyspepsia—Capecitabine—breast cancer	0.000136	0.000283	CcSEcCtD
Glimepiride—Arrhythmia—Epirubicin—breast cancer	0.000136	0.000281	CcSEcCtD
Glimepiride—Visual impairment—Doxorubicin—breast cancer	0.000135	0.000281	CcSEcCtD
Glimepiride—Asthenia—Paclitaxel—breast cancer	0.000135	0.000281	CcSEcCtD
Glimepiride—Decreased appetite—Capecitabine—breast cancer	0.000135	0.000279	CcSEcCtD
Glimepiride—Nausea—Gemcitabine—breast cancer	0.000134	0.000277	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Capecitabine—breast cancer	0.000134	0.000277	CcSEcCtD
Glimepiride—Fatigue—Capecitabine—breast cancer	0.000133	0.000277	CcSEcCtD
Glimepiride—Pruritus—Paclitaxel—breast cancer	0.000133	0.000277	CcSEcCtD
Glimepiride—Vision blurred—Methotrexate—breast cancer	0.000133	0.000276	CcSEcCtD
Glimepiride—Erythema multiforme—Doxorubicin—breast cancer	0.000133	0.000275	CcSEcCtD
Glimepiride—Erythema—Epirubicin—breast cancer	0.000132	0.000274	CcSEcCtD
Glimepiride—Malnutrition—Epirubicin—breast cancer	0.000132	0.000274	CcSEcCtD
Glimepiride—Feeling abnormal—Docetaxel—breast cancer	0.000132	0.000273	CcSEcCtD
Glimepiride—Nausea—Fluorouracil—breast cancer	0.000132	0.000273	CcSEcCtD
Glimepiride—Gastrointestinal pain—Docetaxel—breast cancer	0.000131	0.000271	CcSEcCtD
Glimepiride—Anaemia—Methotrexate—breast cancer	0.000131	0.000271	CcSEcCtD
Glimepiride—Tension—Epirubicin—breast cancer	0.00013	0.000269	CcSEcCtD
Glimepiride—Diarrhoea—Paclitaxel—breast cancer	0.000129	0.000268	CcSEcCtD
Glimepiride—Nervousness—Epirubicin—breast cancer	0.000128	0.000266	CcSEcCtD
Glimepiride—Feeling abnormal—Capecitabine—breast cancer	0.000128	0.000264	CcSEcCtD
Glimepiride—Gastrointestinal pain—Capecitabine—breast cancer	0.000127	0.000262	CcSEcCtD
Glimepiride—Abdominal pain—Docetaxel—breast cancer	0.000126	0.000262	CcSEcCtD
Glimepiride—Leukopenia—Methotrexate—breast cancer	0.000126	0.000262	CcSEcCtD
Glimepiride—Arrhythmia—Doxorubicin—breast cancer	0.000126	0.00026	CcSEcCtD
Glimepiride—Dizziness—Paclitaxel—breast cancer	0.000125	0.000259	CcSEcCtD
Glimepiride—Vision blurred—Epirubicin—breast cancer	0.000125	0.000258	CcSEcCtD
Glimepiride—Urticaria—Capecitabine—breast cancer	0.000123	0.000255	CcSEcCtD
Glimepiride—Abdominal pain—Capecitabine—breast cancer	0.000122	0.000254	CcSEcCtD
Glimepiride—Convulsion—Methotrexate—breast cancer	0.000122	0.000254	CcSEcCtD
Glimepiride—Erythema—Doxorubicin—breast cancer	0.000122	0.000254	CcSEcCtD
Glimepiride—Malnutrition—Doxorubicin—breast cancer	0.000122	0.000254	CcSEcCtD
Glimepiride—Anaemia—Epirubicin—breast cancer	0.000122	0.000253	CcSEcCtD
Glimepiride—Agitation—Epirubicin—breast cancer	0.000121	0.000252	CcSEcCtD
Glimepiride—Tension—Doxorubicin—breast cancer	0.00012	0.000249	CcSEcCtD
Glimepiride—Vomiting—Paclitaxel—breast cancer	0.00012	0.000249	CcSEcCtD
Glimepiride—Rash—Paclitaxel—breast cancer	0.000119	0.000247	CcSEcCtD
Glimepiride—Dermatitis—Paclitaxel—breast cancer	0.000119	0.000246	CcSEcCtD
Glimepiride—Nervousness—Doxorubicin—breast cancer	0.000119	0.000246	CcSEcCtD
Glimepiride—Leukopenia—Epirubicin—breast cancer	0.000118	0.000245	CcSEcCtD
Glimepiride—Headache—Paclitaxel—breast cancer	0.000118	0.000245	CcSEcCtD
Glimepiride—Hypersensitivity—Docetaxel—breast cancer	0.000118	0.000244	CcSEcCtD
Glimepiride—Palpitations—Epirubicin—breast cancer	0.000117	0.000242	CcSEcCtD
Glimepiride—Confusional state—Methotrexate—breast cancer	0.000116	0.000241	CcSEcCtD
Glimepiride—Loss of consciousness—Epirubicin—breast cancer	0.000116	0.000241	CcSEcCtD
Glimepiride—Anaphylactic shock—Methotrexate—breast cancer	0.000115	0.000239	CcSEcCtD
Glimepiride—Vision blurred—Doxorubicin—breast cancer	0.000115	0.000239	CcSEcCtD
Glimepiride—Asthenia—Docetaxel—breast cancer	0.000115	0.000238	CcSEcCtD
Glimepiride—Convulsion—Epirubicin—breast cancer	0.000115	0.000237	CcSEcCtD
Glimepiride—Hypertension—Epirubicin—breast cancer	0.000114	0.000237	CcSEcCtD
Glimepiride—Hypersensitivity—Capecitabine—breast cancer	0.000114	0.000236	CcSEcCtD
Glimepiride—Pruritus—Docetaxel—breast cancer	0.000113	0.000235	CcSEcCtD
Glimepiride—Anaemia—Doxorubicin—breast cancer	0.000113	0.000234	CcSEcCtD
Glimepiride—Thrombocytopenia—Methotrexate—breast cancer	0.000113	0.000234	CcSEcCtD
Glimepiride—Agitation—Doxorubicin—breast cancer	0.000112	0.000233	CcSEcCtD
Glimepiride—Anxiety—Epirubicin—breast cancer	0.000112	0.000232	CcSEcCtD
Glimepiride—Nausea—Paclitaxel—breast cancer	0.000112	0.000232	CcSEcCtD
Glimepiride—Hyperhidrosis—Methotrexate—breast cancer	0.000111	0.000231	CcSEcCtD
Glimepiride—Asthenia—Capecitabine—breast cancer	0.000111	0.00023	CcSEcCtD
Glimepiride—Dry mouth—Epirubicin—breast cancer	0.00011	0.000228	CcSEcCtD
Glimepiride—Anorexia—Methotrexate—breast cancer	0.00011	0.000228	CcSEcCtD
Glimepiride—Pruritus—Capecitabine—breast cancer	0.00011	0.000227	CcSEcCtD
Glimepiride—Leukopenia—Doxorubicin—breast cancer	0.000109	0.000227	CcSEcCtD
Glimepiride—Diarrhoea—Docetaxel—breast cancer	0.000109	0.000227	CcSEcCtD
Glimepiride—Confusional state—Epirubicin—breast cancer	0.000109	0.000225	CcSEcCtD
Glimepiride—Palpitations—Doxorubicin—breast cancer	0.000108	0.000224	CcSEcCtD
Glimepiride—Anaphylactic shock—Epirubicin—breast cancer	0.000108	0.000224	CcSEcCtD
Glimepiride—Hypotension—Methotrexate—breast cancer	0.000108	0.000223	CcSEcCtD
Glimepiride—Loss of consciousness—Doxorubicin—breast cancer	0.000107	0.000223	CcSEcCtD
Glimepiride—Shock—Epirubicin—breast cancer	0.000106	0.00022	CcSEcCtD
Glimepiride—Convulsion—Doxorubicin—breast cancer	0.000106	0.00022	CcSEcCtD
Glimepiride—Diarrhoea—Capecitabine—breast cancer	0.000106	0.00022	CcSEcCtD
Glimepiride—Dizziness—Docetaxel—breast cancer	0.000106	0.000219	CcSEcCtD
Glimepiride—Thrombocytopenia—Epirubicin—breast cancer	0.000106	0.000219	CcSEcCtD
Glimepiride—Hypertension—Doxorubicin—breast cancer	0.000106	0.000219	CcSEcCtD
Glimepiride—Tachycardia—Epirubicin—breast cancer	0.000105	0.000218	CcSEcCtD
Glimepiride—Hyperhidrosis—Epirubicin—breast cancer	0.000104	0.000216	CcSEcCtD
Glimepiride—Insomnia—Methotrexate—breast cancer	0.000104	0.000216	CcSEcCtD
Glimepiride—Anxiety—Doxorubicin—breast cancer	0.000104	0.000215	CcSEcCtD
Glimepiride—Paraesthesia—Methotrexate—breast cancer	0.000104	0.000215	CcSEcCtD
Glimepiride—Anorexia—Epirubicin—breast cancer	0.000103	0.000213	CcSEcCtD
Glimepiride—Dyspnoea—Methotrexate—breast cancer	0.000103	0.000213	CcSEcCtD
Glimepiride—Somnolence—Methotrexate—breast cancer	0.000102	0.000212	CcSEcCtD
Glimepiride—Dizziness—Capecitabine—breast cancer	0.000102	0.000212	CcSEcCtD
Glimepiride—Dry mouth—Doxorubicin—breast cancer	0.000102	0.000211	CcSEcCtD
Glimepiride—Vomiting—Docetaxel—breast cancer	0.000102	0.000211	CcSEcCtD
Glimepiride—Dyspepsia—Methotrexate—breast cancer	0.000101	0.00021	CcSEcCtD
Glimepiride—Rash—Docetaxel—breast cancer	0.000101	0.000209	CcSEcCtD
Glimepiride—Hypotension—Epirubicin—breast cancer	0.000101	0.000209	CcSEcCtD
Glimepiride—Dermatitis—Docetaxel—breast cancer	0.000101	0.000209	CcSEcCtD
Glimepiride—Confusional state—Doxorubicin—breast cancer	0.000101	0.000209	CcSEcCtD
Glimepiride—Decreased appetite—Methotrexate—breast cancer	0.0001	0.000208	CcSEcCtD
Glimepiride—Headache—Docetaxel—breast cancer	0.0001	0.000208	CcSEcCtD
Glimepiride—Anaphylactic shock—Doxorubicin—breast cancer	9.98e-05	0.000207	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Methotrexate—breast cancer	9.95e-05	0.000206	CcSEcCtD
Glimepiride—Fatigue—Methotrexate—breast cancer	9.94e-05	0.000206	CcSEcCtD
Glimepiride—Vomiting—Capecitabine—breast cancer	9.84e-05	0.000204	CcSEcCtD
Glimepiride—Shock—Doxorubicin—breast cancer	9.82e-05	0.000204	CcSEcCtD
Glimepiride—Thrombocytopenia—Doxorubicin—breast cancer	9.77e-05	0.000203	CcSEcCtD
Glimepiride—Rash—Capecitabine—breast cancer	9.76e-05	0.000202	CcSEcCtD
Glimepiride—Insomnia—Epirubicin—breast cancer	9.76e-05	0.000202	CcSEcCtD
Glimepiride—Dermatitis—Capecitabine—breast cancer	9.75e-05	0.000202	CcSEcCtD
Glimepiride—Tachycardia—Doxorubicin—breast cancer	9.74e-05	0.000202	CcSEcCtD
Glimepiride—Headache—Capecitabine—breast cancer	9.7e-05	0.000201	CcSEcCtD
Glimepiride—Paraesthesia—Epirubicin—breast cancer	9.69e-05	0.000201	CcSEcCtD
Glimepiride—Hyperhidrosis—Doxorubicin—breast cancer	9.65e-05	0.0002	CcSEcCtD
Glimepiride—Dyspnoea—Epirubicin—breast cancer	9.62e-05	0.000199	CcSEcCtD
Glimepiride—Somnolence—Epirubicin—breast cancer	9.59e-05	0.000199	CcSEcCtD
Glimepiride—Anorexia—Doxorubicin—breast cancer	9.51e-05	0.000197	CcSEcCtD
Glimepiride—Nausea—Docetaxel—breast cancer	9.5e-05	0.000197	CcSEcCtD
Glimepiride—Feeling abnormal—Methotrexate—breast cancer	9.5e-05	0.000197	CcSEcCtD
Glimepiride—Dyspepsia—Epirubicin—breast cancer	9.5e-05	0.000197	CcSEcCtD
Glimepiride—Gastrointestinal pain—Methotrexate—breast cancer	9.43e-05	0.000195	CcSEcCtD
Glimepiride—Decreased appetite—Epirubicin—breast cancer	9.38e-05	0.000194	CcSEcCtD
Glimepiride—Hypotension—Doxorubicin—breast cancer	9.33e-05	0.000193	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Epirubicin—breast cancer	9.31e-05	0.000193	CcSEcCtD
Glimepiride—Fatigue—Epirubicin—breast cancer	9.3e-05	0.000193	CcSEcCtD
Glimepiride—Nausea—Capecitabine—breast cancer	9.2e-05	0.000191	CcSEcCtD
Glimepiride—Urticaria—Methotrexate—breast cancer	9.16e-05	0.00019	CcSEcCtD
Glimepiride—Abdominal pain—Methotrexate—breast cancer	9.11e-05	0.000189	CcSEcCtD
Glimepiride—Insomnia—Doxorubicin—breast cancer	9.03e-05	0.000187	CcSEcCtD
Glimepiride—Paraesthesia—Doxorubicin—breast cancer	8.96e-05	0.000186	CcSEcCtD
Glimepiride—Dyspnoea—Doxorubicin—breast cancer	8.9e-05	0.000184	CcSEcCtD
Glimepiride—Feeling abnormal—Epirubicin—breast cancer	8.89e-05	0.000184	CcSEcCtD
Glimepiride—ABCC8—Metabolism—IDH1—breast cancer	8.88e-05	0.000844	CbGpPWpGaD
Glimepiride—Somnolence—Doxorubicin—breast cancer	8.87e-05	0.000184	CcSEcCtD
Glimepiride—Gastrointestinal pain—Epirubicin—breast cancer	8.82e-05	0.000183	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—SULT1A1—breast cancer	8.81e-05	0.000838	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GPX4—breast cancer	8.81e-05	0.000838	CbGpPWpGaD
Glimepiride—Dyspepsia—Doxorubicin—breast cancer	8.79e-05	0.000182	CcSEcCtD
Glimepiride—ABCC8—Metabolism—NAT2—breast cancer	8.78e-05	0.000835	CbGpPWpGaD
Glimepiride—Decreased appetite—Doxorubicin—breast cancer	8.68e-05	0.00018	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Doxorubicin—breast cancer	8.62e-05	0.000179	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—GSTA1—breast cancer	8.61e-05	0.000818	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—IDH1—breast cancer	8.61e-05	0.000818	CbGpPWpGaD
Glimepiride—Fatigue—Doxorubicin—breast cancer	8.61e-05	0.000178	CcSEcCtD
Glimepiride—Urticaria—Epirubicin—breast cancer	8.57e-05	0.000178	CcSEcCtD
Glimepiride—Abdominal pain—Epirubicin—breast cancer	8.53e-05	0.000177	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—CYP3A4—breast cancer	8.51e-05	0.000809	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NAT2—breast cancer	8.51e-05	0.000809	CbGpPWpGaD
Glimepiride—Hypersensitivity—Methotrexate—breast cancer	8.49e-05	0.000176	CcSEcCtD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP3A4—breast cancer	8.39e-05	0.000798	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP1B1—breast cancer	8.37e-05	0.000796	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	8.36e-05	0.000795	CbGpPWpGaD
Glimepiride—Asthenia—Methotrexate—breast cancer	8.27e-05	0.000171	CcSEcCtD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP1B1—breast cancer	8.25e-05	0.000785	CbGpPWpGaD
Glimepiride—Feeling abnormal—Doxorubicin—breast cancer	8.22e-05	0.00017	CcSEcCtD
Glimepiride—Gastrointestinal pain—Doxorubicin—breast cancer	8.16e-05	0.000169	CcSEcCtD
Glimepiride—Pruritus—Methotrexate—breast cancer	8.16e-05	0.000169	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—NCOA1—breast cancer	7.98e-05	0.000759	CbGpPWpGaD
Glimepiride—Hypersensitivity—Epirubicin—breast cancer	7.95e-05	0.000165	CcSEcCtD
Glimepiride—Urticaria—Doxorubicin—breast cancer	7.93e-05	0.000164	CcSEcCtD
Glimepiride—Abdominal pain—Doxorubicin—breast cancer	7.89e-05	0.000164	CcSEcCtD
Glimepiride—Diarrhoea—Methotrexate—breast cancer	7.89e-05	0.000163	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—CYP19A1—breast cancer	7.87e-05	0.000748	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP19A1—breast cancer	7.76e-05	0.000738	CbGpPWpGaD
Glimepiride—Asthenia—Epirubicin—breast cancer	7.74e-05	0.00016	CcSEcCtD
Glimepiride—ABCC8—Metabolism—MED12—breast cancer	7.7e-05	0.000732	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—DPYD—breast cancer	7.7e-05	0.000732	CbGpPWpGaD
Glimepiride—Pruritus—Epirubicin—breast cancer	7.63e-05	0.000158	CcSEcCtD
Glimepiride—Dizziness—Methotrexate—breast cancer	7.62e-05	0.000158	CcSEcCtD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	7.59e-05	0.000722	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	7.59e-05	0.000722	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALDOA—breast cancer	7.58e-05	0.00072	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—DPYD—breast cancer	7.46e-05	0.00071	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—MED12—breast cancer	7.46e-05	0.00071	CbGpPWpGaD
Glimepiride—Diarrhoea—Epirubicin—breast cancer	7.38e-05	0.000153	CcSEcCtD
Glimepiride—ABCC8—Metabolism—NCOA3—breast cancer	7.35e-05	0.000699	CbGpPWpGaD
Glimepiride—Hypersensitivity—Doxorubicin—breast cancer	7.35e-05	0.000152	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—ALDOA—breast cancer	7.35e-05	0.000699	CbGpPWpGaD
Glimepiride—Vomiting—Methotrexate—breast cancer	7.33e-05	0.000152	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—COMT—breast cancer	7.31e-05	0.000695	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC2A2—breast cancer	7.3e-05	0.000694	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTP1—breast cancer	7.28e-05	0.000692	CbGpPWpGaD
Glimepiride—Rash—Methotrexate—breast cancer	7.27e-05	0.000151	CcSEcCtD
Glimepiride—Dermatitis—Methotrexate—breast cancer	7.26e-05	0.000151	CcSEcCtD
Glimepiride—Headache—Methotrexate—breast cancer	7.22e-05	0.00015	CcSEcCtD
Glimepiride—CYP2C9—Metapathway biotransformation—COMT—breast cancer	7.21e-05	0.000686	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HADHB—breast cancer	7.19e-05	0.000684	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTP1—breast cancer	7.18e-05	0.000683	CbGpPWpGaD
Glimepiride—Asthenia—Doxorubicin—breast cancer	7.16e-05	0.000148	CcSEcCtD
Glimepiride—ABCC8—Metabolism—CPT1A—breast cancer	7.15e-05	0.00068	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—MTR—breast cancer	7.15e-05	0.00068	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCG2—breast cancer	7.15e-05	0.00068	CbGpPWpGaD
Glimepiride—Dizziness—Epirubicin—breast cancer	7.13e-05	0.000148	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—NCOA3—breast cancer	7.13e-05	0.000678	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC2A2—breast cancer	7.08e-05	0.000673	CbGpPWpGaD
Glimepiride—Pruritus—Doxorubicin—breast cancer	7.06e-05	0.000146	CcSEcCtD
Glimepiride—ABCC8—Metabolism—HPGDS—breast cancer	7.02e-05	0.000667	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HBA1—breast cancer	6.97e-05	0.000663	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—MTR—breast cancer	6.94e-05	0.00066	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CPT1A—breast cancer	6.94e-05	0.00066	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCG2—breast cancer	6.94e-05	0.00066	CbGpPWpGaD
Glimepiride—Vomiting—Epirubicin—breast cancer	6.86e-05	0.000142	CcSEcCtD
Glimepiride—Nausea—Methotrexate—breast cancer	6.85e-05	0.000142	CcSEcCtD
Glimepiride—Diarrhoea—Doxorubicin—breast cancer	6.83e-05	0.000142	CcSEcCtD
Glimepiride—ABCC8—Metabolism—ACHE—breast cancer	6.8e-05	0.000647	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTT1—breast cancer	6.8e-05	0.000647	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HPGDS—breast cancer	6.8e-05	0.000647	CbGpPWpGaD
Glimepiride—Rash—Epirubicin—breast cancer	6.8e-05	0.000141	CcSEcCtD
Glimepiride—Dermatitis—Epirubicin—breast cancer	6.8e-05	0.000141	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—HBA1—breast cancer	6.76e-05	0.000643	CbGpPWpGaD
Glimepiride—Headache—Epirubicin—breast cancer	6.76e-05	0.00014	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—GSTM1—breast cancer	6.69e-05	0.000636	CbGpPWpGaD
Glimepiride—Dizziness—Doxorubicin—breast cancer	6.6e-05	0.000137	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—ACHE—breast cancer	6.6e-05	0.000627	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTT1—breast cancer	6.6e-05	0.000627	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTM1—breast cancer	6.6e-05	0.000627	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—FHL2—breast cancer	6.58e-05	0.000626	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP17A1—breast cancer	6.44e-05	0.000613	CbGpPWpGaD
Glimepiride—Nausea—Epirubicin—breast cancer	6.41e-05	0.000133	CcSEcCtD
Glimepiride—ABCC8—Metabolism—ENO1—breast cancer	6.38e-05	0.000606	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTGS1—breast cancer	6.38e-05	0.000606	CbGpPWpGaD
Glimepiride—Vomiting—Doxorubicin—breast cancer	6.35e-05	0.000132	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—CYP1A1—breast cancer	6.34e-05	0.000603	CbGpPWpGaD
Glimepiride—Rash—Doxorubicin—breast cancer	6.29e-05	0.00013	CcSEcCtD
Glimepiride—Dermatitis—Doxorubicin—breast cancer	6.29e-05	0.00013	CcSEcCtD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP1A1—breast cancer	6.25e-05	0.000595	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP2D6—breast cancer	6.25e-05	0.000595	CbGpPWpGaD
Glimepiride—Headache—Doxorubicin—breast cancer	6.25e-05	0.00013	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—CYP17A1—breast cancer	6.25e-05	0.000594	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ENO1—breast cancer	6.18e-05	0.000588	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTGS1—breast cancer	6.18e-05	0.000588	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NCOA2—breast cancer	6.14e-05	0.000584	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	6.12e-05	0.000582	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP2D6—breast cancer	6.06e-05	0.000577	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ALB—breast cancer	5.96e-05	0.000567	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—FASN—breast cancer	5.95e-05	0.000566	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NCOA2—breast cancer	5.95e-05	0.000566	CbGpPWpGaD
Glimepiride—Nausea—Doxorubicin—breast cancer	5.93e-05	0.000123	CcSEcCtD
Glimepiride—ABCC8—Metabolism—BCHE—breast cancer	5.93e-05	0.000564	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	5.92e-05	0.000563	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC5A5—breast cancer	5.86e-05	0.000557	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—FASN—breast cancer	5.77e-05	0.000549	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—BCHE—breast cancer	5.75e-05	0.000547	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC5A5—breast cancer	5.68e-05	0.00054	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NQO1—breast cancer	5.66e-05	0.000538	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC2A1—breast cancer	5.66e-05	0.000538	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—HRAS—breast cancer	5.52e-05	0.000525	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP3A4—breast cancer	5.51e-05	0.000524	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NQO1—breast cancer	5.48e-05	0.000521	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC2A1—breast cancer	5.48e-05	0.000521	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—GPX2—breast cancer	5.45e-05	0.000518	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP1B1—breast cancer	5.42e-05	0.000516	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—RAF1—breast cancer	5.39e-05	0.000513	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—breast cancer	5.38e-05	0.000512	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—HRAS—breast cancer	5.36e-05	0.000509	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP3A4—breast cancer	5.35e-05	0.000509	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HSP90AA1—breast cancer	5.32e-05	0.000506	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—breast cancer	5.26e-05	0.0005	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP1B1—breast cancer	5.26e-05	0.0005	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NCOA1—breast cancer	5.17e-05	0.000492	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HSP90AA1—breast cancer	5.16e-05	0.00049	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SYNJ2—breast cancer	5.1e-05	0.000485	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—STK11—breast cancer	5.1e-05	0.000485	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP19A1—breast cancer	5.1e-05	0.000485	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NCOA1—breast cancer	5.02e-05	0.000477	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—STK11—breast cancer	4.94e-05	0.00047	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP19A1—breast cancer	4.94e-05	0.00047	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NDUFS3—breast cancer	4.74e-05	0.000451	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—COMT—breast cancer	4.74e-05	0.000451	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTP1—breast cancer	4.72e-05	0.000449	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HMOX1—breast cancer	4.65e-05	0.000442	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ITPR1—breast cancer	4.64e-05	0.000441	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—COMT—breast cancer	4.6e-05	0.000437	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTP1—breast cancer	4.57e-05	0.000435	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—MED12—breast cancer	4.56e-05	0.000434	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HMOX1—breast cancer	4.51e-05	0.000429	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ITPR1—breast cancer	4.5e-05	0.000428	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCB1—breast cancer	4.46e-05	0.000425	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CHST9—breast cancer	4.46e-05	0.000424	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—TYMS—breast cancer	4.38e-05	0.000417	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	4.36e-05	0.000414	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PLA2G4A—breast cancer	4.33e-05	0.000412	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTM1—breast cancer	4.33e-05	0.000412	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NCOR1—breast cancer	4.33e-05	0.000412	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCB1—breast cancer	4.33e-05	0.000412	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—TYMS—breast cancer	4.25e-05	0.000404	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	4.24e-05	0.000403	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—COX11—breast cancer	4.23e-05	0.000402	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PLA2G4A—breast cancer	4.2e-05	0.0004	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NCOR1—breast cancer	4.2e-05	0.0004	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTM1—breast cancer	4.2e-05	0.0004	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	4.16e-05	0.000395	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GPX1—breast cancer	4.15e-05	0.000395	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP1A1—breast cancer	4.11e-05	0.000391	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ERCC2—breast cancer	4.08e-05	0.000388	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—breast cancer	4.03e-05	0.000383	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GPX1—breast cancer	4.02e-05	0.000383	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP1A1—breast cancer	3.98e-05	0.000379	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ERCC2—breast cancer	3.95e-05	0.000376	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SHMT1—breast cancer	3.87e-05	0.000368	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CDA—breast cancer	3.87e-05	0.000368	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—MTHFR—breast cancer	3.83e-05	0.000364	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	3.82e-05	0.000363	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	3.78e-05	0.000359	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLCO1B1—breast cancer	3.72e-05	0.000354	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC2A5—breast cancer	3.72e-05	0.000354	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—MTHFR—breast cancer	3.71e-05	0.000353	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	3.64e-05	0.000346	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APRT—breast cancer	3.59e-05	0.000342	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CAV1—breast cancer	3.53e-05	0.000336	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—FASN—breast cancer	3.53e-05	0.000335	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—breast cancer	3.51e-05	0.000334	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CAV1—breast cancer	3.43e-05	0.000326	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ESRRA—breast cancer	3.38e-05	0.000321	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ANGPTL4—breast cancer	3.38e-05	0.000321	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CG—breast cancer	3.22e-05	0.000306	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	3.21e-05	0.000306	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HADHB—breast cancer	3.2e-05	0.000305	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GPI—breast cancer	3.2e-05	0.000305	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CG—breast cancer	3.12e-05	0.000297	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	3.07e-05	0.000291	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALDH1A1—breast cancer	3.06e-05	0.000291	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALDH7A1—breast cancer	3.06e-05	0.000291	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	3.02e-05	0.000287	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—FHL2—breast cancer	2.93e-05	0.000279	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—UMPS—breast cancer	2.93e-05	0.000279	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PHGDH—breast cancer	2.93e-05	0.000279	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ADSL—breast cancer	2.93e-05	0.000279	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NME1—breast cancer	2.93e-05	0.000279	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HPSE—breast cancer	2.87e-05	0.000273	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LDHB—breast cancer	2.87e-05	0.000273	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—BRIP1—breast cancer	2.87e-05	0.000273	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CD—breast cancer	2.83e-05	0.000269	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALB—breast cancer	2.79e-05	0.000266	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CD—breast cancer	2.74e-05	0.000261	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HMMR—breast cancer	2.72e-05	0.000259	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCC1—breast cancer	2.72e-05	0.000259	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTA3—breast cancer	2.72e-05	0.000259	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALB—breast cancer	2.71e-05	0.000258	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NOS3—breast cancer	2.67e-05	0.000254	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPARGC1B—breast cancer	2.64e-05	0.000251	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NOS3—breast cancer	2.59e-05	0.000246	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.57e-05	0.000244	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.57e-05	0.000244	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTA4—breast cancer	2.49e-05	0.000237	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CA9—breast cancer	2.49e-05	0.000237	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CB—breast cancer	2.47e-05	0.000235	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.46e-05	0.000234	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTGS2—breast cancer	2.44e-05	0.000232	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.43e-05	0.000232	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTA2—breast cancer	2.43e-05	0.000231	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GPX2—breast cancer	2.43e-05	0.000231	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GPX4—breast cancer	2.4e-05	0.000228	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SULT1A1—breast cancer	2.4e-05	0.000228	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CB—breast cancer	2.39e-05	0.000227	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTGS2—breast cancer	2.37e-05	0.000225	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTA1—breast cancer	2.34e-05	0.000223	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—IDH1—breast cancer	2.34e-05	0.000223	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NAT2—breast cancer	2.32e-05	0.00022	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTEN—breast cancer	2.13e-05	0.000203	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.09e-05	0.000199	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTEN—breast cancer	2.07e-05	0.000196	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MED12—breast cancer	2.03e-05	0.000193	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—DPYD—breast cancer	2.03e-05	0.000193	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALDOA—breast cancer	2e-05	0.00019	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NCOA3—breast cancer	1.94e-05	0.000185	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC2A2—breast cancer	1.93e-05	0.000183	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.91e-05	0.000181	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CPT1A—breast cancer	1.89e-05	0.00018	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCG2—breast cancer	1.89e-05	0.00018	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MTR—breast cancer	1.89e-05	0.00018	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HPGDS—breast cancer	1.85e-05	0.000176	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HBA1—breast cancer	1.84e-05	0.000175	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ACHE—breast cancer	1.8e-05	0.000171	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTT1—breast cancer	1.8e-05	0.000171	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP17A1—breast cancer	1.7e-05	0.000162	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ENO1—breast cancer	1.68e-05	0.00016	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTGS1—breast cancer	1.68e-05	0.00016	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.68e-05	0.000159	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.66e-05	0.000157	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP2D6—breast cancer	1.65e-05	0.000157	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NCOA2—breast cancer	1.62e-05	0.000154	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—FASN—breast cancer	1.57e-05	0.000149	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—BCHE—breast cancer	1.56e-05	0.000149	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC5A5—breast cancer	1.55e-05	0.000147	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CA—breast cancer	1.5e-05	0.000143	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NQO1—breast cancer	1.49e-05	0.000142	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC2A1—breast cancer	1.49e-05	0.000142	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.46e-05	0.000139	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CA—breast cancer	1.46e-05	0.000139	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP3A4—breast cancer	1.46e-05	0.000138	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.45e-05	0.000138	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP1B1—breast cancer	1.43e-05	0.000136	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HSP90AA1—breast cancer	1.4e-05	0.000133	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NCOA1—breast cancer	1.37e-05	0.00013	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—STK11—breast cancer	1.35e-05	0.000128	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP19A1—breast cancer	1.35e-05	0.000128	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.26e-05	0.00012	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—COMT—breast cancer	1.25e-05	0.000119	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTP1—breast cancer	1.24e-05	0.000118	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AKT1—breast cancer	1.23e-05	0.000117	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HMOX1—breast cancer	1.23e-05	0.000117	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ITPR1—breast cancer	1.22e-05	0.000116	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AKT1—breast cancer	1.19e-05	0.000113	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCB1—breast cancer	1.18e-05	0.000112	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—TYMS—breast cancer	1.16e-05	0.00011	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.14e-05	0.000109	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NCOR1—breast cancer	1.14e-05	0.000109	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTM1—breast cancer	1.14e-05	0.000109	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GPX1—breast cancer	1.1e-05	0.000104	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP1A1—breast cancer	1.08e-05	0.000103	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ERCC2—breast cancer	1.08e-05	0.000102	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MTHFR—breast cancer	1.01e-05	9.61e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CAV1—breast cancer	9.33e-06	8.87e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.91e-06	8.47e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CG—breast cancer	8.49e-06	8.08e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CD—breast cancer	7.47e-06	7.1e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALB—breast cancer	7.37e-06	7.01e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NOS3—breast cancer	7.05e-06	6.7e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CB—breast cancer	6.51e-06	6.19e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTGS2—breast cancer	6.45e-06	6.13e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTEN—breast cancer	5.62e-06	5.35e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CA—breast cancer	3.97e-06	3.77e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AKT1—breast cancer	3.24e-06	3.08e-05	CbGpPWpGaD
